Ahlawat Sushil K, Singhania Rohit, Al-Kawas Firas H
Curr Treat Options Gastroenterol. 2007 Apr;10(2):102-10. doi: 10.1007/s11938-007-0062-7.
Mirizzi syndrome is an important complication of gallstone disease. If not recognized preoperatively, it can result in significant morbidity and mortality. Preoperative diagnosis may be difficult despite the availability of multiple imaging modalities. Ultrasonography (US), CT, and magnetic resonance cholangiopancreatography (MRCP) are common initial tests for suspected Mirizzi syndrome. Typical findings on US suggestive of Mirizzi syndrome are a shrunken gallbladder, impacted stone(s) in the cystic duct, a dilated intrahepatic tree, and common hepatic duct with a normal-sized common bile duct. The main role of CT is to differentiate Mirizzi syndrome from a malignancy in the area of porta hepatis or in the liver. MRI and MRCP are increasingly playing an important role and have the additional advantage of showing the extent of inflammation around the gallbladder that can help in the differentiation of Mirizzi syndrome from other gallbladder pathologies such as gallbladder malignancy. Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard in the diagnosis of Mirizzi syndrome. It delineates the cause, level, and extent of biliary obstruction, as well as ductal abnormalities, including fistula. ERCP also offers a variety of therapeutic options, such as stone extraction and biliary stent placement. Percutaneous cholangiogram can provide information similar to ERCP; however, ERCP has an additional advantage of identifying a low-lying cystic duct that may be missed on percutaneous cholangiogram. Wire-guided intraductal US can provide high-resolution images of the biliary tract and adjacent structures. Treatment is primarily surgical. Open surgery is the current standard for managing patients with Mirizzi syndrome. Good short- and long-term results with low mortality and morbidity have been reported with open surgical management. Laparoscopic management is contraindicated in many patients because of the increased risk of morbidity and mortality associated with this approach. Endoscopic treatment may serve as an alternative in patients who are poor surgical candidates, such as elderly patients or those with multiple comorbidities. Endoscopic treatment also can serve as a temporizing measure to provide biliary drainage in preparation for an elective surgery.
Mirizzi综合征是胆石症的一种重要并发症。如果术前未被识别,它可能导致严重的发病率和死亡率。尽管有多种影像学检查手段,但术前诊断可能仍有困难。超声检查(US)、CT和磁共振胆胰管造影(MRCP)是疑似Mirizzi综合征常见的初始检查。US上提示Mirizzi综合征的典型表现为胆囊缩小、胆囊管内结石嵌顿、肝内胆管扩张以及肝总管扩张而胆总管管径正常。CT的主要作用是将Mirizzi综合征与肝门区或肝脏的恶性肿瘤相鉴别。MRI和MRCP发挥着越来越重要的作用,并且具有额外的优势,即能够显示胆囊周围炎症的范围,这有助于将Mirizzi综合征与其他胆囊病变(如胆囊恶性肿瘤)相鉴别。内镜逆行胰胆管造影(ERCP)是诊断Mirizzi综合征的金标准。它能明确胆道梗阻的原因、部位和程度,以及导管异常,包括瘘管。ERCP还提供多种治疗选择,如结石取出和胆道支架置入。经皮胆管造影可提供与ERCP类似的信息;然而,ERCP的一个额外优势是能够识别经皮胆管造影可能遗漏的低位胆囊管。导丝引导下的导管内超声可提供胆道及相邻结构的高分辨率图像。治疗主要是手术治疗。开放手术是目前治疗Mirizzi综合征患者的标准方法。据报道,开放手术治疗的短期和长期效果良好,死亡率和发病率较低。由于这种方法相关的发病率和死亡率增加,许多患者禁忌腹腔镜治疗。对于手术条件较差的患者,如老年患者或有多种合并症的患者,内镜治疗可作为一种替代方法。内镜治疗也可作为一种临时措施,用于在择期手术前提供胆道引流。